Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)
Brazil · Delayed Price · Currency is BRL 0.5900
-0.0100 (-1.67%)
Aug 6, 2026, 5:05 PM GMT-3
BVMF:ONCO3 Cash Flow Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -3,841 | -3,624 | -646.19 | 223.62 | 46.26 | -46.9 |
Depreciation & Amortization | 245.71 | 251.01 | 275.45 | 236.9 | 175.15 | 121.71 |
Other Amortization | 50.11 | 46.39 | 50.93 | 20.47 | - | 5.27 |
Loss (Gain) From Sale of Assets | 422.52 | 434.33 | - | - | - | - |
Asset Writedown & Restructuring Costs | 1,137 | 1,151 | 724.91 | 2.6 | 1.96 | 1.1 |
Loss (Gain) From Sale of Investments | 497.98 | 497.98 | - | - | - | - |
Loss (Gain) on Equity Investments | 11.7 | -0.18 | 7.9 | 11.65 | 0.54 | - |
Stock-Based Compensation | 21.3 | 22.18 | 27.65 | 46.84 | 11.08 | 69.16 |
Provision & Write-off of Bad Debts | 361.3 | 218.18 | 175.15 | 163.25 | 99.31 | 48.71 |
Other Operating Activities | 1,119 | 968.7 | -175.66 | -250.16 | -92.55 | 8.96 |
Change in Accounts Receivable | -599.03 | -281.47 | -781.08 | -659.59 | -676.1 | -182.05 |
Change in Inventory | 34.4 | 24.47 | -18.85 | -42.26 | -70.29 | -24.22 |
Change in Accounts Payable | 222.27 | 109.38 | 217.79 | 159.17 | 262.55 | 47.75 |
Change in Income Taxes | -33.57 | -15.14 | 77.33 | 65.88 | -49.98 | 19.13 |
Change in Other Net Operating Assets | 90.31 | 78.61 | -120.19 | -29.92 | 20.43 | -77.91 |
Operating Cash Flow | -260.8 | -118.63 | -184.85 | -51.56 | -271.64 | -9.28 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -168.12 | -168.12 | -214.25 | -311.7 | -300.18 | -201.95 |
Cash Acquisitions | -76.74 | -76.74 | -213.05 | -46.36 | -823.36 | -402.5 |
Investment in Securities | 671.12 | 1,032 | -1,283 | 556.09 | 721.37 | -1,431 |
Other Investing Activities | 36.51 | 5.76 | -10.54 | 29.8 | -8.29 | 5.93 |
Investing Cash Flow | 473.33 | 793.03 | -1,721 | 227.83 | -410.46 | -2,030 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 310.12 | 2,044 | 1,554 | 1,439 | 1,188 |
Long-Term Debt Repaid | - | -778.51 | -1,333 | -598.06 | -831.91 | -544.34 |
Net Debt Issued (Repaid) | -363.05 | -468.39 | 711.26 | 956.15 | 607.39 | 643.31 |
Issuance of Common Stock | 1.09 | 1.09 | 1,500 | 205 | 2.67 | 1,788 |
Repurchase of Common Stock | - | -3.69 | - | -33.74 | -65.02 | -177.09 |
Common Dividends Paid | -31.44 | -36.78 | -11.66 | -59.71 | -18.29 | -26.4 |
Other Financing Activities | -257.49 | -210.02 | -294.19 | -956.29 | -117.93 | -393.48 |
Financing Cash Flow | -650.88 | -717.78 | 1,905 | 111.42 | 408.82 | 1,835 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.06 | 2.18 | 0.57 | -0.19 | -0.35 | 0.42 |
Net Cash Flow | -438.42 | -41.2 | 0.04 | 287.5 | -273.63 | -204.05 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -428.92 | -286.75 | -399.1 | -363.26 | -571.82 | -211.23 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -7.93% | -5.00% | -6.41% | -6.62% | -13.99% | -7.82% |
Free Cash Flow Per Share | -0.46 | -0.33 | -0.65 | -0.68 | -1.07 | -0.51 |
Levered Free Cash Flow | -670.35 | -467.41 | 12.91 | -615.49 | -329.02 | -161.29 |
Unlevered Free Cash Flow | -280.69 | -62.33 | 468.01 | -263.37 | -22.7 | -64.81 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 667.95 | 689.64 | 608 | 490.63 | 348.55 | 128.78 |
Cash Income Tax Paid | 25.65 | 50.83 | 81.82 | 95.98 | 60.44 | 33.5 |
Change in Working Capital | -285.63 | -84.15 | -624.99 | -506.73 | -513.39 | -217.29 |